At present the Weight Management Service is not able to accept referrals for these medications.
The Scottish Medicines Consortium (SMC) has approved the following medications for restricted use in NHS Scotland for weight management:
Liraglutide (Saxenda®)
Semaglutide (Wegovy®)
Tirzepatide (Monjaro®)
NHS Borders does not yet have a pathway for introducing these medications. Until a pathway has been agreed, we will not be able to accept referrals for Liraglutide (Saxenda®), Semaglutide (Wegovy®) and Tirzepatide (Mounjaro®). NHS Borders are currently working on a robust clinical pathway to ensure patient safety.
We will update our website with any futher changes.
The Scottish Government has issued a consensus statement advising the NHS in Scotland to consider a phased implementation of these medicines:
https://www.publications.scot.nhs.uk/files/dcconsensus-statement.pdf
NHS Borders is considering a phased roll out of these medicines for weight management in line with Scottish Government guidance.